SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of pre-clinical data related to the company…
Category: Business
5,736位世界最貧困人士於2019年在Tej Kohli角膜研究所獲贈視力恢復手術
倫敦–(BUSINESS WIRE)–(美國商業資訊)–在總部位於海德拉巴的Tej Kohli角膜研究所4週年慶之際,Tej Kohli基金會已更新其承諾,將自2020年起資助1400萬美元。在2019年期間,5,736位失明或重度視力受損者在Tej Kohli角膜研究所獲得治癒,該所是總部位於倫敦的Tej Kohli基金會與總部位於海德拉巴的世界衛生組織合作中心LV Prasad眼科研究所之間的合作。 Tej Kohli角膜研究所成立於2015年12月,為任何有需求的人士提供免費治療,以解決…
5,736位世界最贫困人士2019年在Tej Kohli角膜研究所获赠视力恢复手术
伦敦–(BUSINESS WIRE)–(美国商业资讯)–在总部位于海得拉巴的Tej Kohli角膜研究所4周年庆之际,Tej Kohli基金会已更新其承诺,将自2020年起资助1400万美元。在2019年期间,5,736位失明或重度视力受损个体在Tej Kohli角膜研究所获得治愈,该所是总部位于伦敦的Tej Kohli基金会与总部位于海得拉巴的世界卫生组织协作中心LV Prasad眼科研究所之间的合作。 Tej Kohli角膜研究所成立于2015年12月,旨在通过向任何有需求的人士提供免费治…
Midwest Vision Partners Announces Partnership With Cleveland Eye Clinic
CHICAGO & CLEVELAND–(BUSINESS WIRE)–Alpine Investors’ Midwest Vision Partners (“MVP”) partners with Cleveland Eye Clinic (“CEC”).
ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institute
LONDON–(BUSINESS WIRE)–On the fourth anniversary of the Tej Kohli Cornea Institute in Hyderabad, the Tej Kohli Foundation has renewed its commitment of $14m of funding from 2020. During 2019 5,736 individuals were cured of blindness or severe visual …
Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today an…
STAAR CFO to Retire in 2020
LAKE FOREST, CA–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that following a successful 24-year career with th…
STAAR Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced it has entered into a strategic alliance with …
FDA Advisory Committee Votes Unanimously to Support the Use of Teprotumumab for the Treatment of Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon today announced the outcome of the FDA Advisory Committee meeting for teprotumumab for the treatment of thyroid eye disease (TED).
FocalPoint Holdings Partners with GreenSky Patient Solutions® to Enable 8,000 Ophthalmology Providers to Provide Patient Financing
ATLANTA–(BUSINESS WIRE)—- $GSKY #eyedoctor–FocalPoint Holdings Partners with GreenSky Patient Solutions® to Enable 8,000 Ophthalmology Providers to provide Patient Financing
Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX) and AgeX Therapeutics, Inc. (NYSE American: AGE), announced today that the United States Patent and Trademark Office (USPTO) has issued U.S…
EnChroma Launches Scenic Viewers for Color Blindness in Partnership with SeeCoast
BERKELEY, Calif. & FAIRHOPE, Ala.–(BUSINESS WIRE)– #colorishere–EnChroma lens technology for color blindness is available in scenic viewers made by SeeCoast, enabling the color blind to enjoy the colors of nature.
Aurinia Prices US$166.7 Million Public Offering of Common Shares
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced th…
Global Glaucoma Surgery Devices Market 2019-2023| Evolving Opportunities with ALLERGAN and Carl Zeiss Meditec | Technavio
LONDON–(BUSINESS WIRE)– #glaucomasurgerydevices–Technavio has been monitoring the global glaucoma surgery devices market since 2016 and the market is poised to grow by USD 1 billion during 2019-2023
Global Optic Neuropathy Pipeline Review, H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. The review provi…
Canon Inc. Realigns Strategy to Prepare for Eye Care Systems Business Growth
TUSTIN, Calif.–(BUSINESS WIRE)–As part of Canon Inc.’s global medical business strategic realignment, the eye care business operations within Canon U.S.A. Inc. will transfer to Canon Medical Systems USA, Inc. effective January 1, 2020. Canon’s shift …
Aerie Pharmaceuticals Announces Appointment of Amine Sinmazisik as Director, Finance
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Global Cataract Surgery Devices and Equipment Market Report 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices And Equipment Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global cataract surgery devices and equipment market was valued at about $3.4 billion in 201…
Opportunities in Global Ophthalmic Surgery Markets, 2019 & Beyond – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Opportunities in Global Ophthalmic Surgery Markets” report has been added to ResearchAndMarkets.com’s offering. Coverage in this report includes a detailed analysis of the current and forecast markets for ophthalmic surger…